Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Overview
The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Double
- Study Primary Completion Date: November 2001
Interventions
- Drug: brimonidine/timolol fixed combination
Clinical Trial Outcome Measures
Primary Measures
- IOP
Participating in This Clinical Trial
Inclusion Criteria
- Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes – Patient requires IOP-lowering drug in both eyes Exclusion Criteria:
- Uncontrolled medical condition – Contraindication to beta-adrenoceptor antagonist or brimonidine therapy
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Allergan
- Provider of Information About this Clinical Study
- Therapeutic Area Head, Allergan, Inc
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.